• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

True-resistant hypertension and serum fibrinogen; much more than a marriage of convenience?

作者信息

Hermida-Ameijeiras Alvaro, Vazquez-Agra Nestor, Pose-Reino Antonio

机构信息

Division of Internal Medicine. University Hospital of Santiago de Compostela, 15706 Santiago de Compostela, A Coruña, Spain.

University of Santiago de Compostela, 15706 Santiago de Compostela, A Coruña, Spain.

出版信息

J Hum Hypertens. 2024 Nov;38(11):731-732. doi: 10.1038/s41371-024-00973-8. Epub 2024 Oct 25.

DOI:10.1038/s41371-024-00973-8
PMID:39455802
Abstract
摘要

相似文献

1
True-resistant hypertension and serum fibrinogen; much more than a marriage of convenience?真性难治性高血压与血清纤维蛋白原；仅仅是一种权宜结合吗？
J Hum Hypertens. 2024 Nov;38(11):731-732. doi: 10.1038/s41371-024-00973-8. Epub 2024 Oct 25.
2
Prognostic impact of fibrinogen in patients with resistant hypertension.纤维蛋白原对顽固性高血压患者的预后影响
J Hum Hypertens. 2024 Dec;38(12):860-866. doi: 10.1038/s41371-024-00964-9. Epub 2024 Oct 4.
3
An Inconvenient Truth: The Unconsidered Benefits of Convenience Polyandry.一个不方便的事实：方便一妻多夫制的未被考虑的好处。
Trends Ecol Evol. 2018 Dec;33(12):904-915. doi: 10.1016/j.tree.2018.10.002. Epub 2018 Oct 28.
4
A Grounded Theory Exploration of the Stages of Relationship Development in Marriages of Convenience in China.中国“假结婚”婚姻关系发展阶段的扎根理论探索
Fam Process. 2021 Dec;60(4):1347-1363. doi: 10.1111/famp.12626. Epub 2021 Jan 6.
5
Electrocardiographic differences in patients with true and pseudo-resistant hypertension.真性和假性难治性高血压患者的心电图差异。
J Hum Hypertens. 2022 Jul;36(7):622-628. doi: 10.1038/s41371-021-00559-8. Epub 2021 Jun 15.
6
Prevalence and clinical characteristics of isolated-office and true resistant hypertension determined by ambulatory blood pressure monitoring.通过动态血压监测确定的孤立诊室和真性耐药高血压的患病率及临床特征。
Chronobiol Int. 2013 Mar;30(1-2):207-20. doi: 10.3109/07420528.2012.701135. Epub 2012 Oct 19.
7
Ambulatory blood pressure monitoring and clinical characteristics of the true and white-coat resistant hypertension.动态血压监测与真性及白大衣抵抗性高血压的临床特征
Clin Exp Hypertens. 2001 Apr;23(3):203-11. doi: 10.1081/ceh-100102660.
8
Apparent and true resistant hypertension: definition, prevalence and outcomes.显性与真性难治性高血压：定义、患病率及转归
J Hum Hypertens. 2014 Aug;28(8):463-8. doi: 10.1038/jhh.2013.140. Epub 2014 Jan 16.
9
HIV disclosure and intimate partner violence among HIV-infected men who have sex with men in marriage of convenience in China.中国男男性行为者假结婚中艾滋病毒披露与亲密伴侣暴力问题
Fam Process. 2024 Dec;63(4):2434-2454. doi: 10.1111/famp.13017. Epub 2024 May 22.
10
Reproductive health in adolescence.青少年生殖健康。
World Health Stat Q. 1994;47(1):31-5.

本文引用的文献

1
2024 ESC Guidelines for the management of elevated blood pressure and hypertension.2024年欧洲心脏病学会高血压管理指南
Eur Heart J. 2024 Oct 7;45(38):3912-4018. doi: 10.1093/eurheartj/ehae178.
2
Consensus Statement on Renal Denervation by the Joint Committee of Japanese Society of Hypertension (JSH), Japanese Association of Cardiovascular Intervention and Therapeutics (CVIT), and the Japanese Circulation Society (JCS).日本高血压学会（JSH）、心血管介入治疗学会（CVIT）和日本循环学会（JCS）联合委员会关于肾脏去神经支配的共识声明。
Circ J. 2024 Sep 25;88(10):1718-1725. doi: 10.1253/circj.CJ-66-0225. Epub 2024 Jul 26.
3
2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA).
2023ESH 动脉高血压管理指南 欧洲高血压学会动脉高血压管理工作组：得到国际高血压学会 (ISH) 和欧洲肾脏协会 (ERA) 的认可。
J Hypertens. 2023 Dec 1;41(12):1874-2071. doi: 10.1097/HJH.0000000000003480. Epub 2023 Sep 26.
4
Efficacy and safety of interleukin-6 inhibition with ziltivekimab in patients at high risk of atherosclerotic events in Japan (RESCUE-2): A randomized, double-blind, placebo-controlled, phase 2 trial.在日本发生动脉粥样硬化事件风险高的患者中使用 ziltivekimab 抑制白细胞介素-6 的疗效和安全性（RESCUE-2）：一项随机、双盲、安慰剂对照、2 期试验。
J Cardiol. 2023 Oct;82(4):279-285. doi: 10.1016/j.jjcc.2023.05.006. Epub 2023 May 19.
5
Implications of Inflammatory and Oxidative Stress Markers in the Attenuation of Nocturnal Blood Pressure Dipping.炎症和氧化应激标志物在夜间血压下降减弱中的意义。
J Clin Med. 2023 Feb 18;12(4):1643. doi: 10.3390/jcm12041643.
6
Fibrinogen Interaction with Astrocyte ICAM-1 and PrP Results in the Generation of ROS and Neuronal Death.纤维蛋白原与星形胶质细胞 ICAM-1 和 PrP 的相互作用导致 ROS 的产生和神经元死亡。
Int J Mol Sci. 2021 Feb 27;22(5):2391. doi: 10.3390/ijms22052391.
7
Inflammation and Apparent Treatment-Resistant Hypertension in Patients With Chronic Kidney Disease.慢性肾脏病患者的炎症与貌似治疗抵抗性高血压
Hypertension. 2019 Apr;73(4):785-793. doi: 10.1161/HYPERTENSIONAHA.118.12358.
8
Global prevalence of resistant hypertension: a meta-analysis of data from 3.2 million patients.全球耐药性高血压患病率：来自 320 万患者数据的荟萃分析。
Heart. 2019 Jan;105(2):98-105. doi: 10.1136/heartjnl-2018-313599. Epub 2018 Aug 7.
9
Treatment-resistant hypertension and the incidence of cardiovascular disease and end-stage renal disease: results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).抗高血压和降脂治疗预防心脏病发作试验（ALLHAT）：治疗抵抗性高血压与心血管疾病和终末期肾病的发病率。
Hypertension. 2014 Nov;64(5):1012-21. doi: 10.1161/HYPERTENSIONAHA.114.03850. Epub 2014 Aug 4.
10
Effects of interleukin-1β inhibition with canakinumab on hemoglobin A1c, lipids, C-reactive protein, interleukin-6, and fibrinogen: a phase IIb randomized, placebo-controlled trial.卡那单抗抑制白介素-1β对血红蛋白 A1c、血脂、C 反应蛋白、白介素-6 和纤维蛋白原的影响：一项 IIb 期随机、安慰剂对照试验。
Circulation. 2012 Dec 4;126(23):2739-48. doi: 10.1161/CIRCULATIONAHA.112.122556. Epub 2012 Nov 5.